Binita was educated at Cambridge University and trained at several London hospitals, including Kings College Hospital. She moved to the Children's Hospital of Philadelphia in 2000 and completed her fellowship in GI, Hepatology and Nutrition. She joined the faculty in 2006 and developed a strong interest in cholestatic liver disease, specifically Alagille syndrome. She joined the faculty at the Hospital for Sick Children, Toronto in 2009 as a Hepatologist and Clinician-Investigator continuing to work on biliary diseases and utilizing stem cell biology to develop disease models.

Maliha Ahmad, MD, is a skilled hepatologist with expertise in liver disease at St. Joseph's Health. She is board-certified in internal medicine and fellowship-trained in hepatology and liver transplants. Dr. Ahmad has nearly two decades of experience in both general and transplant medicine and uses her fascination with how the body works to help restore the body's balance.

Pierre M. Gholam, MD, is an expert gastroenterologist and hepatologist with over 20 years of academic and clinical practice. He holds a primary specialization in advanced liver diseases, oncology, and transplantation logistics.

MD

Join Dr Binita Kamath and Dr Cara Mack on a journey from diagnosis to long-term management in paediatric cholestatic liver diseases. This session will explore early diagnosis, nutritional support, multidisciplinary care, prognostic biomarkers, and strategies for patient management. 

Industry Supporter: Ipsen

Progressive familial intrahepatic cholestasis (PFIC) is a group of disorders associated with the accumulation of toxic bile acids and progressive liver injury. In this presentation, hear an adult patient share their experience living with PFIC, while Dr. Saab reviews the signs/symptoms, the role of genetic testing in diagnosis, and treatment considerations for adults with PFIC.

Industry Supporter: Mirum Pharmaceuticals

This session will highlight evolving approaches to second-line treatment in Primary Biliary Cholangitis (PBC) through a case-based discussion. It will provide practical insights and foster a dynamic exchange between leading hepatologists.

Industry Supporter: Ipsen